Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation
Authors:
- 1 April 2015
- journal article
- Published by Elsevier in Neuroscience
- Vol. 290, 530-542
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81373384)
- NSFC-Guangdong Joint Fund (U1032006)
This publication has 50 references indexed in Scilit:
- Amyloid-β and TauJAMA Neurology, 2014
- Neuroprotective effects of donepezil against cholinergic depletionAlzheimer's Research & Therapy, 2013
- Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s diseasePsychopharmacology, 2013
- Nonsteroidal anti‐inflammatory drug use and the risk of cognitive impairment and Alzheimer's diseaseAlzheimer's & Dementia, 2012
- Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohortNeurology, 2009
- Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodiesNeurology, 2007
- Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-ProteinThe American Journal of Pathology, 2004
- Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 AlleleThe American Journal of Pathology, 2003
- Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxinNature, 2000
- Insulin-Degrading Enzyme: Stable Expression of the Human Complementary DNA, Characterization of its Protein Product, and Chromosomal Mapping of the Human and Mouse GenesMolecular Endocrinology, 1990